Lithetha ukuthini elithi “Sula”?
Isilwanyana asiluthwali utshintsho. Ayiyi kuphuhlisa isifo kwaye ayiyi kudlula.
Inja I-Canine Malignant Hyperthermia (MH)
Discover the importance of DNA testing for Canine Malignant Hyperthermia (MH) in dogs. This genetic disorder can lead to severe reactions during anesthesia, placing your furry friend at risk. By identifying the MH gene mutation through a simple DNA test, pet owners can make informed decisions about their dog's health and safety. Early detection allows for proactive management, ensuring a safer experience during veterinary procedures. Investing in a DNA test for Canine Malignant Hyperthermia can ultimately save lives and enhance your dog's well-being. Consult your veterinarian today to learn more about this vital genetic screening. Protect your pup with knowledge and peace of mind!
Ushunqulelo : MH
Utshintsho oluhlaziyiweyo : RYR1 c.1643T>C
Ilifa : I-Autosomal Dominant
Isifinyezo
MH
Ukuqwalaselwa rhoqo
Ubunzima beklinikhi
Ukuhlelwa kweklinikhi
Izifo zeMetabolic
Uguqulo oluhlalutyiweyo
RYR1 c.1643T>C
p.(V548A)
p.(V548A)
Indlela yelifa
I-Autosomal Dominant
Isishwankathelo sovavanyo:
Canine Malignant Hyperthermia (MH) is a rare genetic disorder triggered by certain anesthetic agents in dogs. It leads to a severe and uncontrolled increase in body temperature, muscle rigidity, and metabolic disturbances. The condition is often linked to mutations in the ryanodine receptor gene. Prompt recognition and immediate treatment are crucial to prevent serious complications or death. Preventive measures include genetic testing and avoiding specific anesthetics in at-risk breeds.
Ifumaneka kwipakethi : Basic
Olu vavanyo lweDNA lubandakanyiwe ukuqala kwipakethi yethu Basic - kwaye ikwayinxalenye yeepakethi Basic, Standard, Advanced, Complete.
Jonga i-DNA Test Packs →Khetha ipakethi ekufanelekela ukufuya kwakho okanye ubuchule bempilo yezilwanyana zakho.
Introduction to Canine Malignant Hyperthermia (MH)
Canine Malignant Hyperthermia (MH) is a rare but serious genetic disorder that affects certain dog breeds. It is characterized by an abnormal and severe response to specific stressors, such as anesthesia or extreme heat, leading to a rapid increase in body temperature and metabolic crisis. If not recognized and treated promptly, MH can be fatal for the affected dog.
Understanding the Condition
Malignant Hyperthermia in dogs is caused by a hereditary defect in the regulation of calcium within muscle cells. This defect leads to uncontrolled muscle contractions and a significant increase in metabolic activity, resulting in a rapid rise in core body temperature. Symptoms often include muscle rigidity, rapid breathing, increased heart rate, and a sudden onset of hyperthermia. The condition is often triggered by certain anesthetic agents or stress, making perioperative management critical.
Genetic Basis of Canine MH
The disorder is inherited in a manner similar to that observed in humans, with specific genetic mutations affecting calcium regulation pathways. Dogs carrying these mutations are predisposed to developing MH when exposed to triggering factors. Identifying affected dogs through DNA testing allows breeders and veterinarians to make informed decisions to prevent the spread of the disorder and to implement appropriate management strategies for affected animals.
Indima yoVavanyo lweDNA
DNA testing for canine MH involves analyzing specific genetic markers associated with the disorder. This test provides valuable information about an individual dog's genetic status, helping to identify carriers or affected animals. Early detection through DNA testing can assist in making preventative choices, such as avoiding certain medications or stressful situations that could trigger a crisis, thereby safeguarding the health and well-being of the dog.
Importance of Diagnosis and Management
Accurate diagnosis of MH through DNA testing is essential for effective management. Dogs identified as at risk can be provided with tailored anesthetic protocols, monitored closely during procedures, and kept in a stress-free environment. Additionally, knowing a dog’s genetic status helps inform breeding decisions to reduce the prevalence of the disorder within a breed population.
Inzala yamkelwe kuvavanyo : I-Canine Malignant Hyperthermia (MH)
- Bearded Collie
- Border Collie
- Doberman Pinscher
- Farm Collie
- German Shepherd Dog
- Labrador Retriever
- Old Farm Collie
- Rough Collie
- Scottish Collie
- Scottish Rough Collie
- Scottish Smooth Collie
- Smooth Collie
🧬 Interpretation of genotypes MH
Genotype
Ubume
🟡 N/N
Non-carrier - Akukho Mngcipheko
🟡 N/MH
Umthwali-Usemngciphekweni
❌ MH/MH
Uchaphazeleka - Usemngciphekweni
FAQ: ukuqonda ingcaciso
Ngaba "Umthwali" unzulu?
Akunjalo. Esi silwanyana sisempilweni ngokuqhelekileyo kodwa sinokudlulisela inguqulelo yemfuza yemfuza inzala.
Kuthekani ukuba isilwanyana “Sichaphazelekile”?
Iphethe iikopi ezimbini eziguqulweyo. Iimpawu zeklinikhi zilindeleke ngokuxhomekeke isifo. Akufunekanga ikhuliswe.
Kutheni kukho umahluko phakathi kwendoda/yebhinqa?
Ezinye izifo zinxulunyaniswa nesondo, ngoko intetho yazo iyahluka ngokuxhomekeke kwi isini sesilwanyana.
Cingela Inzala
N/N (Non-carrier)
N/MH (Umthwali)
MH/MH (Echaphazelekayo)
DNA Test FAQ
Olu vavanyo lweDNA lufumanisa ntoni?
This DNA test detects the mutation associated with Canine Malignant Hyperthermia (MH) in order to identify clear, carrier, or at-risk animals.
Kutheni uvavanya isilwanyana esizalayo?
Uvavanyo lweDNA lunceda abafuyi bacwangcise ukukhwelana okukhuselekileyo kunye nokunciphisa umngcipheko wokudlulisela utshintsho kwinzala.
Ithini indlela yelifa kolu vavanyo?
Indlela yelifa echazwe kolu vavanyo yi-Autosomal Dominant.
Loluphi utshintsho oluhlalutywayo kolu vavanyo?
This test analyses the mutation RYR1 c.1643T>C.
Ngaba isilwanyana esithwalayo siyachaphazeleka?
Akunjalo. Ukutolika kuxhomekeke kwipateni yelifa kunye nesiphumo se-genotype.
Iimbekiselo
Roberts M C, Mickelson J R, Patterson E E, Nelson T E, Armstrong P J, Brunson D B, Hogan K. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology. 2001 Sep;95(3):716-25. doi: 10.1097/00000542-200109000-00026.